Human medicines European public assessment report (EPAR): Simulect, basiliximab, Graft Rejection;Kidney Transplantation, Date of authorisation: 09/10/1998, Revision: 28, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 27 October 2023 - 8:13

Human medicines European public assessment report (EPAR): Simulect, basiliximab, Graft Rejection;Kidney Transplantation, Date of authorisation: 09/10/1998, Revision: 28, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/simulect

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters